Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations

Background. IPX066 is an extended-release (ER) oral formulation of carbidopa-levodopa (CD-LD). Following an initial peak at about one hour, plasma LD concentrations are maintained for about 4-5 hours. Objective. To present dosing factors that may affect the successful conversion to ER CD-LD from oth...

Full description

Saved in:
Bibliographic Details
Main Authors: John C. Morgan, Rohit Dhall, Robert Rubens, Sarita Khanna, Suneel Gupta
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2018/9763057
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items